
Join to View Full Profile
7050 Parkway DrLa Mesa, CA 91942
Phone+1 858-774-5157
Fax+1 858-731-1021
Dr. Jenkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Frederick Jenkin, DO, is based in La Mesa, CA, and specializes in Occupational Medicine. He completed his education with a medical degree from the Chicago College of Osteopathic Medicine at Midwestern University, and pursued multiple residencies, including in Occupational Medicine at Letterman Army Medical Center and Radiology-Diagnostic at Fitzsimons Army Medical Center. He also has training in Preventive Medicine at the University of Hawaii John A Burns School of Medicine and Family Medicine at Swedish Hospital. Dr. Jenkin has experience in areas such as interventional neuroradiology, endovascular neurosurgery, cerebrovascular disease, toxicology, disability evaluation, and worker's compensation injuries. He has also been involved in a clinical trial focused on evaluating glycemic effects, safety, and tolerability of Metformin Delayed Release in patients with Type 2 Diabetes Mellitus.
Education & Training
- University of Hawaii John A Burns School of MedicineResidency, Preventive Medicine, 1997 - 1998
- Letterman Army Medical CenterResidency, Occupational Medicine, 1984 - 1986
- Fitzsimons Army Medical CenterResidency, Radiology-Diagnostic, 1981 - 1982
- Swedish HospitalResidency, Family Medicine, 1976 - 1978
- Advocate Illinois Masonic Medical CenterInternship, Transitional Year, 1975 - 1976
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1975
Certifications & Licensure
- CA State License 1984 - 2026
- TX State License 1979 - 2012
- IL State License 1976 - 1996
- American Board of Preventive Medicine Occupational Medicine
Clinical Trials
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: